Biosimilar insulins: a E uropean perspective
| Autor: | J. H. DeVries, S. C. L. Gough, L. Heinemann, Jacek Kiljanski |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
insulin
diabetes business.industry Endocrinology Diabetes and Metabolism Insulins Drugs generic Biosimilar Legislation Drug Biotechnology Europe Clinical Practice Reference product Endocrinology Biosimilar Pharmaceuticals regulatory requirements Internal Medicine Drugs Generic Humans Medicine biosimilars Engineering ethics business Review Articles |
| Zdroj: | Diabetes, Obesity & Metabolism |
| ISSN: | 1463-1326 1462-8902 |
| DOI: | 10.1111/dom.12410 |
| Popis: | Biosimilar insulins are likely to enter clinical practice in Europe in the near future. It is important that clinicians are familiar with and understand the concept of biosimilarity and how a biosimilar drug may differ from its reference product. The present article provides an overview of biosimilars, the European regulatory requirements for biosimilars and safety issues. It also summarizes the current biosimilars approved in Europe and the key clinical issues associated with the use of biosimilar insulins. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text